Dinabak

Dynabac is a macrolide antibiotic produced by Eli Lilly in the United States of America.

Basic facts about Dinabak:

1. Country of origin - United States of America
2. Pharm group - antibiotics of the macrolide and azalide group
3. Manufacturer - Eli Lilly (USA)
4. International name: dirithromycin
5. Dosage form - 250 mg tablets

Dirithromycin, marketed under the brand name Dinabac, belongs to the group of macrolide antibiotics. It has a bacteriostatic effect, inhibiting protein synthesis in bacterial cells.

Dinabac is indicated for infections of the upper and lower respiratory tract, infections of the skin and soft tissues. Tablets of 250 mg are taken orally, the course of treatment averages from 5 to 10 days.

Dinabac is a well-tolerated antibiotic and side effects are rare. The main manufacturer of the drug is an American pharmaceutical company